Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.00 – $8.95
88% from low
No one on the platform currently holds ABL.
No tracked institution reports a position in ABL as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-02 | $0.2000 | 2025-12-17 |
No one on the platform has traded ABL yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $260M | +19.7% | $1.00 | $0.86–$1.06 | 8.5× | 4 |
| 2027 | $288M | +11.1% | $1.13 | $0.99–$1.33 | 7.5× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-26 | $0.20 | $0.07 | -62.5% |
| 2025-11-06 | $0.18 | $0.20 | +11.1% |
| 2025-08-07 | $0.16 | $0.22 | +37.5% |
| 2025-05-08 | $0.16 | $0.18 | +12.5% |
| 2025-03-27 | $0.13 | $0.16 | +23.1% |
| 2024-11-07 | $0.14 | $0.20 | +42.9% |
| 2024-08-12 | $0.13 | $0.18 | +38.5% |
| +0.76% |
| $651M |
| — |
| EGBNEagle Bancorp, Inc. | $28.78 | +0.07% | $878M | — |
| HQLTekla Life Sciences Investors | $21.15 | -0.42% | $643M | — |
Source: Financial Modeling Prep · peers by sector/industry